Target intelligence / Profile preview

Blood circulation promotion in TCM theory

Molecular classification
Other
01

Overview

This entry does not correspond to a defined molecule, receptor, enzyme, transporter, or gene, but rather refers to a therapeutic principle central to Traditional Chinese Medicine (TCM) aiming to remedy "blood stasis" by promoting blood circulation. TCM achieves these effects through herbal medicines, acupuncture, and other therapies, targeting system-level processes such as improved hemodynamics, microvascular integrity, and balanced platelet activity. These interventions have been used in the context of cardiovascular diseases, diabetes complications, chronic kidney disease, and cancer, but mapping this principle to a canonical molecular target is inappropriate. Numerous herbs and compounds are cited as "blood circulation promoting" but should be referenced individually if a molecular target is needed. Modern drugs like aspirin and heparin overlap with some mechanistic underpinnings in TCM.

Other names
Promote blood circulation" (TCM principle)Activate blood circulation and remove blood stasisBlood stasis resolution therapyInvigorating blood/qiBlood stasis syndrome treatment
02

Mechanism of action

Improve microcirculation, inhibit platelet aggregation, modulate TXA₂/PGI₂ balance, protect vascular endothelium, inhibit Na⁺/K⁺-ATPase (leading to increased myocardial contractility), reduce oxidative stress, and regulate lipid metabolism

03

Biological functions

Other (system-level effects: improve microcirculation, modulate hemodynamics, reduce platelet aggregation, regulate endothelial function)
04

Disease associations

Cardiovascular diseaseDiabetes mellitus and microvascular complicationsChronic kidney diseaseCancer (especially tumor stasis)
05

Safety considerations

Hemorrhagic risk (if combined with anticoagulants/antiplatelet drugs)herb-drug interactionssyndrome specificity (TCM diagnosis required for proper use)variable evidence quality and lack of standardization among herbal preparations
06

Interacting drugs

TCM compounds and formulas, such as Salvia miltiorrhiza, Panax notoginseng, Angelica sinensis, Typhae pollen, Ligusticum wallichii, Carthamus tinctorius, Caulis Spatholobi, leech extracts, and formula preparations like Guanxin II, Taohongsiwu Decoction, and Honghua injection, as well as modern drugs with similar mechanistic overlaps like heparin and aspirin
07

Biomarkers

TXA₂/PGI₂ ratioplasma TXB₂6-keto-PGF1αmarkers of endothelial functionplatelet aggregation measures

Beyond the preview

Go deeper on Blood circulation promotion in TCM theory.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood circulation promotion in TCM theory.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call